Amedeo Smart

Free Medical Literature Service



Drug Resistance

  Free Subscription

Articles published in
    February 2021
  1. WANG S, Hou F, Yao YF, Pan D, et al
    Efficient establishment of reactivatable latency by an acyclovir-resistant herpes simplex virus 1 thymidine kinase substitution mutant with reduced neuronal replication.
    Virology. 2021;556:140-148.
    >> Share

    August 2020
  2. TANG J, Zhang SX, Zhang J, Li XY, et al
    Profile and generation of reduced neuraminidase inhibitor susceptibility in highly pathogenic avian influenza H7N9 virus from human cases in Mainland of China, 2016-2019.
    Virology. 2020;549:77-84.
    >> Share

    February 2020
  3. FANG QQ, Huang WJ, Li XY, Cheng YH, et al
    Effectiveness of favipiravir (T-705) against wild-type and oseltamivir-resistant influenza B virus in mice.
    Virology. 2020;545:1-9.
    >> Share

  4. ALEXANDRE K, Malatji K, Mulaudzi T
    Comparison of the antiviral activity of the microbicide candidate griffithsin and its tandemers derivatives against different modes of HIV-1 transmission.
    Virology. 2020;544:12-20.
    >> Share

    September 2019
  5. MEJER N, Galli A, Ramirez S, Fahnoe U, et al
    Ribavirin inhibition of cell-culture infectious hepatitis C genotype 1-3 viruses is strain-dependent.
    Virology. 2019;540:132-140.
    >> Share

    August 2019
  6. GE Y, Chi Y, Min X, Zhao K, et al
    The evolution and characterization of influenza A(H7N9) virus under the selective pressure of peramivir.
    Virology. 2019;536:58-67.
    >> Share

    October 2018
  7. BAUER D, Keller J, Alt M, Schubert A, et al
    Corrigendum to "Antibody-based immunotherapy of acyclovir resistant ocular herpes simplex virus infection" [Virology 512 (2017) 194-200].
    Virology. 2018 Oct 2. pii: S0042-6822(18)30283.
    >> Share

    August 2018
  8. ZARUBAEV VV, Pushkina EA, Borisevich SS, Galochkina AV, et al
    Selection of influenza virus resistant to the novel camphor-based antiviral camphecene results in loss of pathogenicity.
    Virology. 2018;524:69-77.
    >> Share

  9. GALLEGO I, Gregori J, Soria ME, Garcia-Crespo C, et al
    Resistance of high fitness hepatitis C virus to lethal mutagenesis.
    Virology. 2018;523:100-109.
    >> Share

    October 2017
  10. BAUER D, Keller J, Alt M, Schubert A, et al
    Antibody-based immunotherapy of aciclovir resistant ocular herpes simplex virus infections.
    Virology. 2017;512:194-200.
    >> Share

    May 2017
  11. WADA Y, Orba Y, Sasaki M, Kobayashi S, et al
    Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus.
    Virology. 2017;505:102-112.
    >> Share

    July 2016
  12. ARNDT WD, White SD, Johnson BP, Huynh T, et al
    Monkeypox virus induces the synthesis of less dsRNA than vaccinia virus, and is more resistant to the anti-poxvirus drug, IBT, than vaccinia virus.
    Virology. 2016;497:125-135.
    >> Share

  13. AGUDO R, de la Higuera I, Arias A, Grande-Perez A, et al
    Involvement of a joker mutation in a polymerase-independent lethal mutagenesis escape mechanism.
    Virology. 2016;494:257-66.
    >> Share

    March 2016
  14. GARG H, Lee RT, Maurer-Stroh S, Joshi A, et al
    HIV-1 adaptation to low levels of CCR5 results in V3 and V2 loop changes that increase envelope pathogenicity, CCR5 affinity and decrease susceptibility to Maraviroc.
    Virology. 2016;493:86-99.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016